Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1994 1
1996 2
1999 1
2000 3
2001 6
2002 8
2003 10
2004 11
2005 16
2006 18
2007 23
2008 44
2009 38
2010 46
2011 55
2012 74
2013 73
2014 84
2015 111
2016 118
2017 119
2018 92
2019 115
2020 129
2021 132
2022 100
2023 100
2024 104
2025 112
2026 24

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,564 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean chin jy[Author] (99 results)?
Controlled-release nanoparticle of toll-like receptors-7/8 agonist enhances immune activation and inhibits gastric cancer in a preclinical mouse model.
Kim HM, Jeong K, Jeong J, Jin SM, Yoo J, Yoo YR, Shin JY, Park DJ, Lee HJ, Yang HK, Lee HS, Oh DY, Lim YT, Jung K, Kong SH. Kim HM, et al. Among authors: shin jy. Cancer Cell Int. 2026 Feb 9. doi: 10.1186/s12935-026-04191-9. Online ahead of print. Cancer Cell Int. 2026. PMID: 41664140 Free article. No abstract available.
Long-term effectiveness on glycemic control of insulin compared to combined oral antidiabetic drugs for initial intensive treatment in newly diagnosed type 2 diabetes: A duplicated target trial.
Kim TH, Hwang Y, Woo S, Lee K, Son Y, Park S, Kim H, Shin JY, Cho Y, Shin D, Cho D, Lee KJ, Rhee SY, Yon DK. Kim TH, et al. Among authors: shin jy. Medicine (Baltimore). 2026 Jan 30;105(5):e47235. doi: 10.1097/MD.0000000000047235. Medicine (Baltimore). 2026. PMID: 41630246 Free PMC article.
Impact of KRAS Mutations and Co-Alterations on Outcomes in Stage III Nonsquamous NSCLC Treated With Chemoradiation and Immunotherapy.
Mankuzhy NP, Santo V, Shin JY, Chaunzwa TL, Gelblum DY, Wu AJ, McMillan MT, Ma J, Billing D, Iyengar P, Simone CB 2nd, Offin M, Schoenfeld AJ, Arbour KC, Alessi J, Pecci F, Garbo E, Gariazzo E, Awad MM, Gomez DR, Chaft JE, Ricciuti B, Shaverdian N. Mankuzhy NP, et al. Among authors: shin jy. J Thorac Oncol. 2026 Jan 29:103565. doi: 10.1016/j.jtho.2026.103565. Online ahead of print. J Thorac Oncol. 2026. PMID: 41619904
1,564 results